BridgeMD
New treatment option for Gallbladder Cancer
Official title The Effect in Wedge Resection and IVb/V Resection of the Liver for Gallbladder Cancer
ClinicalTrials.gov ID: NCT02920554
What this study is testing
- What it's testing
- The extent of hepatic resection for gallbladder cancer can be done from a wedge resection to 4b/5 bisegmentectomy. This study aims to compare the recurrence rates and survival rates between wedge resection group and bisegmentectomy group.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 19 to 80
You may be able to join if
- Patients with T2 or T3 gallbladder cancer on preoperative CT exam
- Patients who are pathologically diagnosed as T2 or T3 gallbladder cancer after initial simple cholecystectomy
You likely can't join if
- Peritoneal seeding or distant metastasis
- Impossible to resect the cancer radically
- Pathologically diagnosed to other malignancy such as adenosquamous carcinoma, sarcoma, etc.
- R1 or R2 resection were pathologically diagnosed.
The study team makes the final eligibility decision.
Where it's taking place
- Suwon, South Korea
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 19 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Suwon, South Korea. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.